Hopp til hovedinnhold
Toggle navigation
Live markets
Search
Search
Search
Search
My profile
My Subscriptions
Watchlists
Quote alerts
Create account
Sign in
NB
FR
EN
PT
NL
NB
DE
IT
Hjem
Company Press Releases
Company press releases
Abonner
Filtre
Filtre
Oppdater
Nullstill
Icon After
Dato
Toggle Visibility
Alle
I dag
Denne uken
Denne måneden
Tilpasset datosøk
Fra
Til
Kategori
Toggle Visibility
Alliances and agreements
Annen informasjonspliktig regulatorisk informasjon
Change in Capital
Commercial operations
Commercial results
Corporate life
Dividend
Eks.dato
Endringer i rettighetene til aksjer / verdipapirer
Flagging
General meeting / Board Meeting
Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll
Ikke-informasjonspliktige pressemeldinger
Income
Innsideinformasjon
Joint venture
Journal / appointments
Kapital- og stemmerettsendringer
Legal
Meetings / events
Meldepliktig handel for primærinnsidere
Mergers, Acquiqitions, Transferts
New
New establishment
News contracts
Other financial transaction
Other subject
Polls / Surveys
Products and services
Prospekt / opptaksdokument
Rapportering om betaling til myndigheter (land-for-land rapportering)
Rating
Renteregulering
Sales
Share history
Share introduction and issues
Takeover bids
Trends / Analyses
Utsteders meldeplikt ved handel i egne aksjer
Valg av hjemstat
Årsrapporter og revisjonsberetninger
Leverandør
Toggle Visibility
ActusNewsWire
BusinessWire
EQS Group
Euronext
GlobeNewswire
Les Echos
Marketwire
Modular Finance
Oslo Børs Newspoint
PR Newswire
Viser 201 - 233 av 233 resultater
Tid
Selskap
Tittel
Sektor
Kategori
03 May 2022
17:45 CEST
MEDIAN TECHNOLOGIES
Median Technologies : Déclaration du nombre total de droits de vote et du nombre d’actions composant le capital au 30 avril 2022
10101015 Software
Legal
03 May 2022
17:45 CEST
MEDIAN TECHNOLOGIES
Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of April 30th, 2022
10101015 Software
Legal
21 Apr 2022
17:45 CEST
MEDIAN TECHNOLOGIES
Median Technologies publie ses résultats annuels 2021 et son niveau d’activité pour le premier trimestre 2022
10101015 Software
Commercial results
21 Apr 2022
17:45 CEST
MEDIAN TECHNOLOGIES
Median Technologies Reports Full-Year 2021 Results and Business Indicators for the First Quarter of 2022
10101015 Software
Commercial results
08 Apr 2022
17:45 CEST
MEDIAN TECHNOLOGIES
Median Technologies : Déclaration du nombre total de droits de vote et du nombre d’actions composant le capital au 31 mars 2022
10101015 Software
Legal
08 Apr 2022
17:45 CEST
MEDIAN TECHNOLOGIES
Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of March 31st, 2022
10101015 Software
Legal
25 Mar 2022
17:45 CET
MEDIAN TECHNOLOGIES
Median Technologies Brings Forward Its 2021 Annual Results Publication to April 21, 2022
10101015 Software
Legal
25 Mar 2022
17:45 CET
MEDIAN TECHNOLOGIES
Median Technologies avance la publication de ses résultats annuels 2021 au 21 avril 2022
10101015 Software
Legal
22 Mar 2022
17:45 CET
MEDIAN TECHNOLOGIES
Median Technologies Announces Design Completion of its iBiopsy® Lung Cancer Screening End-to-end CADe/CADx Software as Medical Device (SaMD) with Outstanding Sensitivity & Specificity Performance
10101015 Software
New
22 Mar 2022
17:45 CET
MEDIAN TECHNOLOGIES
Median Technologies annonce avoir terminé la mise au point de son logiciel dispositif médical iBiopsy® Lung Cancer Screening CADe/CADx qui atteint des performances de sensibilité et de spécificité exceptionnelles
10101015 Software
New
10 Mar 2022
17:45 CET
MEDIAN TECHNOLOGIES
Median Technologies répond aux conditions d’éligibilité du dispositif PEA-PME
10101015 Software
Legal
09 Mar 2022
17:45 CET
MEDIAN TECHNOLOGIES
Median Technologies : Déclaration du nombre total de droits de vote et du nombre d’actions composant le capital au 28 février 2022
10101015 Software
Legal
09 Mar 2022
17:45 CET
MEDIAN TECHNOLOGIES
Median Technologies: Disclosure of total number of voting rights and number of shares in the capital as of February 28th, 2022
10101015 Software
Legal
03 Mar 2022
17:45 CET
MEDIAN TECHNOLOGIES
Median Technologies Files FDA 513(g) Regulatory Submission for iBiopsy® Lung Cancer Screening CADe/CADx Software as Medical Device
10101015 Software
New
03 Mar 2022
17:45 CET
MEDIAN TECHNOLOGIES
Median Technologies dépose un dossier 513(g) auprès de la FDA pour son logiciel dispositif médical iBiopsy® Lung Cancer Screening CADe/CADx
10101015 Software
New
01 Mar 2022
17:45 CET
MEDIAN TECHNOLOGIES
Median Technologies to Participate in the Cowen’s 42nd Annual Health Care Conference
10101015 Software
Meetings / events
01 Mar 2022
17:45 CET
MEDIAN TECHNOLOGIES
Median Technologies participera à la 42ème conférence annuelle Health Care de Cowen
10101015 Software
Meetings / events
08 Feb 2022
17:45 CET
MEDIAN TECHNOLOGIES
Median Technologies: Disclosure of total number of voting rights and number of shares in the capital as of January 31st, 2022
10101015 Software
Legal
08 Feb 2022
17:45 CET
MEDIAN TECHNOLOGIES
Median Technologies : Déclaration du nombre total de droits de vote et du nombre d’actions composant le capital au 31 janvier 2022
10101015 Software
Legal
17 Jan 2022
17:45 CET
MEDIAN TECHNOLOGIES
Median Technologies Announces 2021 Revenue of €20.5 Million, Up 52%, and a Strengthened Cash Position of €39 Million
10101015 Software
Income
17 Jan 2022
17:45 CET
MEDIAN TECHNOLOGIES
Median Technologies annonce un chiffre d’affaires 2021 de 20,5 m€ en hausse de 52%, et une trésorerie renforcée à 39 m€
10101015 Software
Income
14 Jan 2022
17:45 CET
MEDIAN TECHNOLOGIES
Median Technologies: Half Year Liquidity Contract Statement
10101015 Software
Legal
14 Jan 2022
17:45 CET
MEDIAN TECHNOLOGIES
Median Technologies : Bilan semestriel du contrat de liquidité
10101015 Software
Legal
10 Jan 2022
17:45 CET
MEDIAN TECHNOLOGIES
Median Technologies : Déclaration du nombre total de droits de vote et du nombre d’actions composant le capital au 31 décembre 2021
10101015 Software
Legal
10 Jan 2022
17:45 CET
MEDIAN TECHNOLOGIES
Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of December 31st, 2021
10101015 Software
Legal
05 Jan 2022
17:45 CET
MEDIAN TECHNOLOGIES
Median Technologies annonce d’excellentes performances de détection (CADe1) de nodules pulmonaires pour iBiopsy® Lung Cancer Screening
10101015 Software
New
05 Jan 2022
17:45 CET
MEDIAN TECHNOLOGIES
Median Technologies Announces Outstanding Lung Nodule Detection (CADe1) Performance for iBiopsy® Lung Cancer Screening
10101015 Software
New
04 Jan 2022
17:45 CET
MEDIAN TECHNOLOGIES
Median Technologies : Calendrier de communication financière du premier semestre 2022
10101015 Software
Meetings / events
04 Jan 2022
17:45 CET
MEDIAN TECHNOLOGIES
Median Technologies: Financial Communications Schedule for the First Half of 2022
10101015 Software
Meetings / events
06 Dec 2021
17:45 CET
MEDIAN TECHNOLOGIES
Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of November 30th, 2021
10101015 Software
Legal
06 Dec 2021
17:45 CET
MEDIAN TECHNOLOGIES
Median Technologies : Déclaration du nombre total de droits de vote et du nombre d’actions composant le capital au 30 novembre 2021
10101015 Software
Legal
23 Nov 2021
17:45 CET
MEDIAN TECHNOLOGIES
Median Technologies Announces New Outstanding Performance for its iBiopsy® Lung Cancer Screening CADx1 With a Focus on Stage 1 Lung Cancer Characterization
10101015 Software
Meetings / events
23 Nov 2021
17:45 CET
MEDIAN TECHNOLOGIES
Median Technologies annonce de nouvelles performances exceptionnelles pour le diagnostic iBiopsy® (CADx1) LCS portant spécifiquement sur la caractérisation du cancer pulmonaire de stade 1
10101015 Software
Meetings / events
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Sider
«
« First
‹
‹‹
3
4
5
Company press releases subscription
×
To subscribe to Press releases from this issuer, visit the Subscription to Company news section in
Hjem
Markeder
Amsterdam
Cash Products
Aksjer
AEX index Stocks
AEX ESG Stocks
Indekser
Fond
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksopsjoner
Indeksfutures
Aksjeopsjoner
Utbyttederivater
Aksjefutures
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Brussel
Cash products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
Expert Market
BEL 20 Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Expert Market
Dublin
Stocks
Euronext regulated
Euronext Growth
ISEQ 20 Stocks
Indices
Funds
Bonds
Irish Government Bonds
DOL
Lisboa
Cash Products
Aksjer
Euronext regulated
Euronext Access
PSI Stocks
Indekser
Obligasjoner
Derivater
Indeksfutures
Stock options
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Milan
Cash Products
Stocks
Euronext Milan
Euronext Growth Milan
Euronext Star Milan
Euronext Global Equity Market
EuroTLX
Trading After Hours
MIB ESG Stocks
Bonds
MOT
Euronext Access Milan
EuroTLX
Structured Products
SeDeX
EuroTLX
ETFs
Funds
Derivative products
All derivatives
Index futures
Index options
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
IPOs
Oslo
Aksjer, renter, indekser
Aksjer
Oslo Børs
Euronext Growth
Euronext Expand
Top performers
OBX aksjer
OBX ESG aksjer
OSEBX aksjer
OSEFX Aksjer
Seafood Aksjer
Shipping Aksjer
Aksjeindekser
Obligasjoner
Oslo Børs
Nordic Alternative Bond Market
Obligasjonsindekser
ETFer
Fond
Derivater
Derivative products
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Finanskalender
Primærinnsidere
Paris
Cash Products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
CAC 40 Stocks
CAC 40 ESG Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Aksjer
All Markets directories
All Markets
Euronext regulated
Euronext Growth
Euronext Access
Euronext Expand
Euronext Global Equity Market
EuroTLX
Trading After Hours
Selskapsmeldinger
Latest
Archive
Nye aksjenoteringer
Alle aksjenoteringer
Euronext Growth advisors
Euronext Tech Leaders
Family business
Indekser
Directory
Grønne indekser
Indices documents
Indices news
Indekser høringer
Kontakter Euronext-indekser
ETF-er
Directory
Grønne ETF-er
Fond
Directory
ESG Funds
Oslo Mutual Funds
Obligasjoner
Grønne obligasjoner
1.5° Bonds
All Markets directories
All Markets
Amsterdam
Brussels
Dublin
Lisbon
Oslo
Milan
Paris
Strukturerte produkter
Directory / search
Bid-Only trading status
Trading Turbos in the Netherlands
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
ETF opsjoner
Kontraktsspesifikasjoner
Tick sizes
Rapportering av handler
Leverandørkoder markedsdata
Råvarer
Quotes
Quotes snapshot
Milling Wheat futures
Rapeseed futures
Corn futures
European Durum Wheat Futures
Milling Wheat options
Rapeseed options
Corn options
Bortfallskalendre
Bortfall
Wholesale Trading
Commitments of Traders (CoT) report
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Knowledge Centre
Bid & Ask
Options Investing E-learning
Contract Specifications
Position Management
Intrinsic Value
Premium & Valuation
Moneyness
Positions
Euronext News
Ressurser
Statistikk & rapporter
Quality of execution
Åpningstider
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Key Information Document
Class level
Product group level
Notices / Corporate actions
Cash Notices / Corporate actions
Derivatives corporate actions
All Corporate Actions
Latest
Unusual Contract Sizes, Dividends
Corporate Action Services
Corporate Action Policies
Derivatives notices
Markedshendelser
Suspenderte instrumenter
Stressed Market Conditions
Brudd på Double Cap limits
Ekstraordinære markedsforhold
Diverse meldinger
Market status
Medlemsliste
Issuers compliance
Hvor du finner hva